Development and Pilot Testing of an Encounter Tool for Shared Decision Making About the Treatment of Graves' Disease

Brito, Juan P.; Castañeda-Guarderas, Ana; Gionfriddo, Michael R.; Ospina, Naykky M Singh; Maraka, Spyridoula; Dean, Diana S.; Castro, M. Regina; Fatourechi, Vahab; Gharib, Hossein; Stan, Marius N.; Branda, Megan E.; Bahn, Rebecca S.; Montori, Víctor M.

doi:10.1089/thy.2015.0277

Cited by 46 publications

(29 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[17][18][19][20][21][22][23] Recordings were audiovisual or audio-only based on the preferences of the patients and their clinicians at the time of enrollment. Of the 272 complete videos available for analyses from these trials, we included all the videos that were recorded in specialty care (51) and selected a random sample of 61 videos from the 221 remaining primary care videos stratified by treatment arm (decision aid use) to complete a sample of 112 videos.…”

Section: Methodsmentioning

confidence: 99%

Humor During Clinical Practice: Analysis of Recorded Clinical Encounters

et al. 2018

Self Cite

View full text Add to dashboard Cite

Section: Methodsmentioning

confidence: 99%

Humor During Clinical Practice: Analysis of Recorded Clinical Encounters

et al. 2018

Self Cite

View full text Add to dashboard Cite

“…Ablative therapies include radioactive iodine treatment (RAI) or the surgical removal of the thyroid tissue. All available treatment options are effective and relatively safe and the initial therapeutic strategy for a newly diagnosed patient with GH remains a choice that the patient and the treating physician could take together after discussing each of the treatment options, including among others the drawbacks and the potential side effects (36,37).…”

Section: Prediction Of the Risk Of Recurrence After Antithyroid Drugsmentioning

confidence: 99%

MANAGEMENT OF ENDOCRINE DISEASE: Predictive scores in autoimmune thyroid disease: are they useful?

Effraimidis

2019

European Journal of Endocrinology

View full text Add to dashboard Cite

Prediction models are of a great assistance for predicting the development of a disease, detecting or screening undiagnosed patients, predicting the effectiveness of a treatment and helping toward better decision-making. Recently, three predictive scores in the field of autoimmune thyroid disease (AITD) have been introduced: The Thyroid Hormones Event Amsterdam (THEA) score: a predictive score of the development of overt AITD, the Graves’ Events After Therapy (GREAT) score: a prediction score for the risk of recurrence after antithyroid drugs withdrawal and the Prediction Graves’ Orbitopathy (PREDIGO) score: a prediction score for the development of Graves’ orbitopathy in newly diagnosed patients with Graves’ hyperthyroidism. Their construction, clinical applicability, the possible preventative measurements which can be taken to diminish the risks and the potential future developments which can improve the accuracy of the predictive scores are discussed in this review.

show abstract

“…The choice depends on objective medical criteria (risk of recurrence, indications and contraindications for each option) and on the patient's preference: i.e., expectations and fears. The pros and cons of each option should therefore be explained [1][2][3][4][5][6] ( Table 1).…”

mentioning

confidence: 99%

“…Choice of treatment strategy is a major element of management. As none of the 3 options shows clear superiority [3], the feasibility, advantages and drawbacks of each should be discussed in detail with the patient and family [5]. Where there are no specific contraindications, the patient's fears and expectations can be taken fully into account.…”

mentioning

confidence: 99%

“…Radioiodine will tend to be chosen by patients seeking relatively rapid definitive control of hyperthyroidism but not wishing to undergo surgery, and who are willing to accept irradiation and the need for longcourse thyroid hormone treatment. And surgery will tend to be chosen by patients seeking very rapid definitive control of hyperthyroidism but not wishing to be exposed to radiation and who are not unduly worried about the risks inherent to surgery -and for whom an experienced medical and surgical team is available [1,2,4,5,7,8].…”

mentioning

confidence: 99%

See 1 more Smart Citation

Treatment of adult Graves’ disease

Corvilain

Hamy

Brunaud³

et al. 2018

Annales d'Endocrinologie

View full text Add to dashboard Cite

Treatment strategy in Graves' disease firstly requires recovery of euthyroid status by antithyroid therapy. Treatment modalities, precautions, advantages and side-effects are to be discussed with the patient. No particular treatment modality has demonstrated superiority. Pregnancy or pregnancy project affects choice of treatment and monitoring. Graves' orbitopathy is liable to be aggravated by iodine-131 treatment and requires pre-treatment assessment. Iodine-131 treatment aims at achieving hypothyroidism. Thyroid surgery for Graves' disease should preferably be performed by an expert team. In case of recurrence of hyperthyroidism, the various treatment options should be discussed with the patient. Empiric treatment of thyroid dermopathy uses local corticosteroids in occlusive dressing.

show abstract

Development and Pilot Testing of an Encounter Tool for Shared Decision Making About the Treatment of Graves' Disease

Cited by 46 publications

References 20 publications

Humor During Clinical Practice: Analysis of Recorded Clinical Encounters

Humor During Clinical Practice: Analysis of Recorded Clinical Encounters

MANAGEMENT OF ENDOCRINE DISEASE: Predictive scores in autoimmune thyroid disease: are they useful?

Treatment of adult Graves’ disease

Contact Info

Product

Resources

About